Cargando…
Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma
Primary liver cancer is one of the most common malignant tumors in China. The vast majority of primary liver cancer are hepatocellular carcinoma. Due to its high incidence and mortality from HCC, HCC has always been a feared type of cancer. Liver transplantation, as one of the important means to tre...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399574/ https://www.ncbi.nlm.nih.gov/pubmed/37545535 http://dx.doi.org/10.3389/fimmu.2023.1227756 |
_version_ | 1785084271448293376 |
---|---|
author | Ju, Feng Wang, Dawei Huang, Lan Jiang, Chun Gao, Ce Xiong, Cunquan Zhai, Guanghua |
author_facet | Ju, Feng Wang, Dawei Huang, Lan Jiang, Chun Gao, Ce Xiong, Cunquan Zhai, Guanghua |
author_sort | Ju, Feng |
collection | PubMed |
description | Primary liver cancer is one of the most common malignant tumors in China. The vast majority of primary liver cancer are hepatocellular carcinoma. Due to its high incidence and mortality from HCC, HCC has always been a feared type of cancer. Liver transplantation, as one of the important means to treat advanced liver cancer, has brought new hope to patients. However, as patients have been in a state of immunosuppression after liver transplantation, these patients face new problems of HCC recurrence and metastasis. A increasing number of studies have proved that blocking the PD-1/PD-L1 signaling pathway and restoring the immune killing inhibition of T cells can produce better therapeutic effects on tumors and chronic infectious diseases. As a promising treatment in the field of tumor immunotherapy, PD-1/PD-L1 inhibitors have achieved important results in liver cancer patients, but their application in liver transplantation patients is still highly controversial. This paper will introduce the mechanism of action of PD-1/PD-L1 signaling pathway and the current basic and clinical studies of PD-1/PD-L1 signaling pathway associated with immune response in HCC transplantation. |
format | Online Article Text |
id | pubmed-10399574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103995742023-08-04 Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma Ju, Feng Wang, Dawei Huang, Lan Jiang, Chun Gao, Ce Xiong, Cunquan Zhai, Guanghua Front Immunol Immunology Primary liver cancer is one of the most common malignant tumors in China. The vast majority of primary liver cancer are hepatocellular carcinoma. Due to its high incidence and mortality from HCC, HCC has always been a feared type of cancer. Liver transplantation, as one of the important means to treat advanced liver cancer, has brought new hope to patients. However, as patients have been in a state of immunosuppression after liver transplantation, these patients face new problems of HCC recurrence and metastasis. A increasing number of studies have proved that blocking the PD-1/PD-L1 signaling pathway and restoring the immune killing inhibition of T cells can produce better therapeutic effects on tumors and chronic infectious diseases. As a promising treatment in the field of tumor immunotherapy, PD-1/PD-L1 inhibitors have achieved important results in liver cancer patients, but their application in liver transplantation patients is still highly controversial. This paper will introduce the mechanism of action of PD-1/PD-L1 signaling pathway and the current basic and clinical studies of PD-1/PD-L1 signaling pathway associated with immune response in HCC transplantation. Frontiers Media S.A. 2023-07-20 /pmc/articles/PMC10399574/ /pubmed/37545535 http://dx.doi.org/10.3389/fimmu.2023.1227756 Text en Copyright © 2023 Ju, Wang, Huang, Jiang, Gao, Xiong and Zhai https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Ju, Feng Wang, Dawei Huang, Lan Jiang, Chun Gao, Ce Xiong, Cunquan Zhai, Guanghua Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma |
title | Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma |
title_full | Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma |
title_fullStr | Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma |
title_full_unstemmed | Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma |
title_short | Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma |
title_sort | progress of pd-1/pd-l1 signaling in immune response to liver transplantation for hepatocellular carcinoma |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399574/ https://www.ncbi.nlm.nih.gov/pubmed/37545535 http://dx.doi.org/10.3389/fimmu.2023.1227756 |
work_keys_str_mv | AT jufeng progressofpd1pdl1signalinginimmuneresponsetolivertransplantationforhepatocellularcarcinoma AT wangdawei progressofpd1pdl1signalinginimmuneresponsetolivertransplantationforhepatocellularcarcinoma AT huanglan progressofpd1pdl1signalinginimmuneresponsetolivertransplantationforhepatocellularcarcinoma AT jiangchun progressofpd1pdl1signalinginimmuneresponsetolivertransplantationforhepatocellularcarcinoma AT gaoce progressofpd1pdl1signalinginimmuneresponsetolivertransplantationforhepatocellularcarcinoma AT xiongcunquan progressofpd1pdl1signalinginimmuneresponsetolivertransplantationforhepatocellularcarcinoma AT zhaiguanghua progressofpd1pdl1signalinginimmuneresponsetolivertransplantationforhepatocellularcarcinoma |